ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TNGX Tango Therapeutics Inc

7.89
0.28 (3.68%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Tango Therapeutics Inc TNGX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.28 3.68% 7.89 09:59:59
Open Price Low Price High Price Close Price Previous Close
7.60 7.52 8.02 7.89 7.61
more quote information »

Recent News

Date Time Source Heading
02/4/202407:48BWTango Therapeutics Announces Inducement Grants Under Nasdaq..
18/3/202422:00BWTango Therapeutics Reports Fourth Quarter and Full Year 2023..
06/3/202423:00BWTango Therapeutics to Participate in Upcoming Investor..
06/3/202408:47GLOBETango Therapeutics to Highlight Preclinical Data on..
09/2/202413:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202413:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:00EDGAR2Form 8-K - Current report
06/2/202408:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202408:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:00GLOBETango Therapeutics to Present at the Guggenheim Healthcare..
06/1/202408:05GLOBETango Therapeutics Announces Inducement Grants Under Nasdaq..
04/1/202418:47PRNUSMedivirĀ“s licensee, Tango Therapeutics, has dosed the first..
03/1/202423:00GLOBETango Therapeutics Announces First Patient Dosed in Phase..
13/11/202323:00GLOBETango Therapeutics to Highlight Preclinical Data on PRMT5..
08/11/202323:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202323:07EDGAR2Form 8-K - Current report
08/11/202323:00GLOBETango Therapeutics Reports Third Quarter 2023 Financial..
07/11/202323:00GLOBETango Therapeutics to Present at the Jefferies London..
03/11/202307:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202308:23EDGAR2Form SC 13D/A - General statement of acquisition of..
18/9/202321:00GLOBETango Therapeutics to Highlight Preclinical Data on..
12/9/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
06/9/202321:00GLOBETango Therapeutics Announces FDA Clearance of..
05/9/202321:00GLOBETango Therapeutics to Participate in the H.C. Wainwright..
01/9/202321:34EDGAR2Form S-3 - Registration statement under Securities Act of..
01/9/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202306:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/8/202320:04EDGAR2Form 8-K - Current report
30/8/202307:08GLOBETango Therapeutics Announces Updates to Its Board of..
28/8/202321:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
22/8/202306:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/8/202306:40EDGAR2Form SC 13D/A - General statement of acquisition of..
10/8/202321:24EDGAR2Form 8-K - Current report
10/8/202321:00GLOBETango Therapeutics Announces $80 million Private Placement..
07/8/202321:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202321:25EDGAR2Form 8-K - Current report
07/8/202321:00GLOBETango Therapeutics Reports Second Quarter 2023 Financial..
24/7/202321:00GLOBETango Therapeutics Announces First Patient Dosed in TNG260..
01/6/202321:00GLOBETango Therapeutics to Participate in Upcoming Investor..
09/5/202321:00GLOBETango Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock